Kimberly Archer

Kimberly Archer serves as a Senior Clinical Research Scientist at Genmab since March 2023, focusing on Phase 1/2 studies for Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. Previously, Kimberly worked at Bristol Myers Squibb as a Clinical Scientist in Hematology, leading Phase 1/2 studies for Multiple Myeloma from November 2019 to March 2023. Kimberly also held multiple roles at Celgene, including Lead IRT Systems Analyst, and was a Project Leader at ICON plc, managing clinical trial operations. Earlier experience includes positions as a Data Processor/Data Reviewer at Clinforce @ Merck and Insurance Registrar at Warren Hospital. Kimberly earned a Bachelor of Science degree in Biology with a minor in Chemistry from The College of New Jersey and completed studies at Warren County Community College in Biology and Chemistry.